•
Jun 30, 2023

Nkgen Biotech Q2 2023 Earnings Report

Total Revenue
$0
EPS
-$0.59
Previous year: $0.05
-1280.0%
Gross Profit
$0
Cash and Equivalents
$41.5K
Previous year: $1.26M
-96.7%
Free Cash Flow
-$552K
Total Assets
$63.6M
Previous year: $174M
-63.4%

Nkgen Biotech

Nkgen Biotech